Meeting
2021 ASCO Annual Meeting
Role of cytoreductive nephrectomy (CN) in metastatic renal cell carcinoma (mRCC).
Authors
Pooja Ghatalia
Fox Chase Cancer Center, Philadelphia, PA
Pooja Ghatalia , Elizabeth A. Handorf , Mengying Deng , Matthew R. Zibelman , Philip Abbosh , Fern Anari , Richard E. Greenberg , Rosalia Viterbo , David Chen , Marc C. Smaldone , Alexander Kutikov , Daniel M. Geynisman , Robert Guy Uzzo
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Kidney and Bladder
Track
Genitourinary Cancer—Kidney and Bladder
Sub Track
Kidney Cancer
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 4582)
DOI
10.1200/JCO.2021.39.15_suppl.4582
Abstract #
4582
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
The role of cytoreductive nephrectomy and systemic therapy in the management of tumor thrombus in patients with metastatic renal cell carcinoma.
First Author: Abhenil Mittal
Poster
2022 ASCO Genitourinary Cancers Symposium
SWOG S1931 (PROBE): Phase III randomized trial of immune checkpoint inhibitor (ICI) combination regimen with or without cytoreductive nephrectomy (CN) in advanced renal cancer.
First Author: Ulka N. Vaishampayan
Poster
2021 Genitourinary Cancers Symposium
Prognostic value of simple blood biomarkers of systemic inflammation for metastatic renal cell carcinoma (mRCC) patients who undergo cytoreductive nephrectomy (CNx).
First Author: Jigi Moudgil-Joshi
Poster
2021 Genitourinary Cancers Symposium
The impact of hypertension on response rates in patients with renal cell carcinoma.
First Author: Diana Maslov